SMTL ID : 8hv3.1

Crystal structure of EGFR_DMX in complex with covalently bound fragment 4

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL(Non-covalent)

PE5.1: 8 residues within 4Å: Chain A: P.79, H.80, N.123, V.126, Q.127, K.130, Q.156, H.157 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.127 Water bridges: A:K.130

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 3 residues within 4Å: Chain A: S.219, P.241, P.244 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.219

1 x MWU: ~{N}-pyridin-2-ylprop-2-enamide(Covalent)

MWU.3: 8 residues within 4Å: Chain A: A.50, C.82, M.97, Q.98, L.99, M.100, L.151, T.161 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.50, A:M.97, A:L.151 Hydrogen bonds: A:Q.98, A:M.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuki, N. et al., A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase. Rsc Med Chem (2023)

Release Date

2023-12-13

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence